Radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma：analysis of the therapeutic results and prognostic factors
10.3969/j.issn.1008-794X.2015.10.023
- VernacularTitle:射频消融治疗复发性肝癌疗效及预后因素分析
- Author:
Wei REN
;
Wei YANG
- Publication Type:Journal Article
- Keywords:
hepatocellular carcinoma;
radiofrequency ablation;
recurrence;
prognosis
- From:Journal of Interventional Radiology
2015;(10):923-927
- CountryChina
- Language:Chinese
-
Abstract:
Based on both domestic and abroad research results concerning the local therapeutic efficacy, influence factors, survival time and prognosis of radiofrequency ablation (RFA) in treating recurrent hepatocellular carcinoma (HCC), this paper aims to make a review of medical literatures about RFA treatment of recurrent HCC that were published in Chinese and in English during the period from 2005 to 2014, and to analyze the related factors that may influence the local therapeutic efficacy and survival rate. The results indicate that the recurrent tumor size, tumor number, recurrence interval, serum alpha fetoprotein (AFP) level, serum prothrombin, etc. are important factors that will affect the therapeutic efficacy of recurrent HCC. At the same time, the results point out that the study of imaging predictors can help suggest the different recurrent types, which is very useful in making individualized follow-up strategy and in monitoring tumor recurrence. Local treatment, with RFA being the main method, together with comprehensive therapies, including other new technologies and new drugs, will improve the current clinical situation in treating recurrent HCC.
